Research · Sep 3, 2026
[ESE] ESCO Technologies Thesis 2026: Defense Filtration Drives Aerospace Utility Capital Return
ESCO Technologies Inc. (NYSE: ESE) FY2025 revenue ~$1.30-1.40B (+10-15%) with adj. EPS ~$5.85-6.30 reflecting continued post-2024 ~$1.30-1.40B aggregate Aerospace & Defense + Test Equipment + Utility Solutions Group (USG) revenue (~$0.65-0.70B aggregate Aerospace & Defense + ~$0.30-0.34B aggregate Test + ~$0.35-0.40B aggregate Utility Solutions Group post-March 2025 Doble Engineering + post-October 2024 SM&P acquisitions) under continued President + CEO Bryan Sayler since November 2023 (~2-year tenure as ESCO CEO; selected post-November 2023 succeeded Vic Richey retirement). One of the largest US specialty Aerospace & Defense + Test Equipment + Utility Solutions companies. Founded 1990 as Esco Manufacturing Holding Company by Vic Richey post-Emerson Electric Subsidiary spin-off (~35-year heritage); selected post-1990 NYSE listing; selected post-1990-2025 ~$3B+ aggregate cumulative tuck-in M&A platform expansion (PTI Technologies 2007 + NSI-MI Technologies 2010 + Morgan Schaffer + Vanguard Instruments 2017 + Crissair 2018 + VACCO 2020); selected post-October 2024 ~$580M+ SM&P (Submarine Manufacturing & Products) acquisition; selected post-November 2023 Bryan Sayler CEO appointment; selected post-March 2025 ~$1.4B+ Doble Engineering Co. acquisition (Doble + Morgan Schaffer + Vanguard Instruments + Manta Test Systems Utility Test + Diagnostic Equipment). Headquartered in St. Louis Missouri; ~3,000-3,500 employees globally with global Aerospace & Defense + Test Equipment + Utility Solutions manufacturing footprint. Three primary segments: Aerospace & Defense ~50%+ ($0.65-0.70B), USG ~28%+ ($0.35-0.40B), Test ~25% ($0.30-0.34B). Geographic mix: US ~75%+ + Europe + selected various aggregate international ~25%. Aerospace & Defense Filtration + Submarine pipeline (~$0.65-0.70B): ~$0.65-0.70B aggregate Aerospace & Defense revenue (~50%+ revenue mix); selected primary PTI (PTI Technologies + Crissair + VACCO) Aerospace & Defense Filtration + Fluid Control; selected ~$2-3B Aerospace & Defense backlog; selected Lockheed Martin (F-35) + Boeing + RTX (Pratt & Whitney) + GE Aerospace + Northrop Grumman + General Dynamics (Submarine Industrial Base) ~80%+ prime contractor exposure; selected post-October 2024 ~$580M+ SM&P Submarine Industrial Base specialty addition. Utility Solutions + Test + Doble Engineering pipeline: selected continued post-March 2025 ~$1.4B+ Doble Engineering Co. acquisition (Doble + Morgan Schaffer + Vanguard Instruments + Manta Test Systems Utility Test + Diagnostic Equipment); selected USG ~$0.35-0.40B revenue (~28%+); selected Test ~$0.30-0.34B revenue (~25%; NSI-MI + ETS-Lindgren EMC + RF Test); selected ~$300-350M annual Aerospace & Defense bookings. President + CEO Bryan Sayler since November 2023 (~2-year tenure); CFO Christopher Tucker. Capital position: ~$0.32 aggregate annual dividend (~5%+ aggregate payout ratio; ~0.2-0.3% aggregate dividend yield); minimal opportunistic buybacks; aggregate capital return ~$10-25M FY2025 (post-March 2025 Doble Engineering Capex-heavy); net leverage ~3.0-3.5x Net Debt/EBITDA (post-March 2025 Doble integration leverage); investment-grade Baa2/BBB credit rating; ~26-27M diluted shares; weighted average debt maturity ~5-6 years. FY2026 thesis: Aerospace & Defense Filtration + Submarine pipeline + Utility Solutions + Test + Doble Engineering pipeline + ~$2-3B Aerospace & Defense backlog + ~80%+ prime contractor exposure (Lockheed F-35 + Boeing + RTX + GE + Northrop Grumman + General Dynamics) + post-October 2024 SM&P integration + post-March 2025 Doble Engineering integration. Risks: TransDigm + Heico + Curtiss-Wright + Moog + Mercury Systems + Hubbell + Roper Technologies + Eaton + Itron + Landis+Gyr competitive displacement + Defense budget cycle considerations + F-35 + Submarine production cycle considerations + post-March 2025 Doble Engineering integration considerations + Federal Reserve interest rate cycle considerations + Utility regulatory cycle considerations + post-March 2025 ~3.0-3.5x net leverage absorption considerations.